Gastroesophageal Junction Cancer Latest Advances
Find the Latest Research About Gastroesophageal Junction Cancer
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1154 publications
Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction cancer: KEYNOTE-859 Q-TWiST analysis.
Journal: Immunotherapy
Published: April 11, 2026
Exploratory analysis of HER2-positive/CLDN18.2-positive metastatic gastric and gastroesophageal junction cancer toward future therapeutic development.
Journal: ESMO gastrointestinal oncology
Published: March 11, 2026
Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary.
Journal: Future oncology (London, England)
Published: March 02, 2026
Tertiary lymphoid structures guided opportunities and challenges for immunotherapy in early gastroesophageal junction cancer and low rectal cancer.
Journal: Human vaccines & immunotherapeutics
Published: February 26, 2026
Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field.
Journal: Journal of internal medicine
Published: February 14, 2026
Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD).
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer.
Journal: Human vaccines & immunotherapeutics
Published: January 12, 2026
Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in locally advanced gastric cancer: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: December 31, 2025
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients.
Journal: JCO oncology practice
Published: December 19, 2025
Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets.
Journal: Nature reviews. Gastroenterology & hepatology
Published: December 18, 2025
Last Updated: 04/28/2026